➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca

Last Updated: February 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sevirumab

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Sevirumab?

Sevirumab is an investigational drug.

There have been 4 clinical trials for Sevirumab. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are HIV Infections, Cytomegalovirus Retinitis, and Retinitis. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Sandoz, and Facet Biotech.

Recent Clinical Trials for Sevirumab
TitleSponsorPhase
A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSFacet BiotechPhase 2
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2

See all Sevirumab clinical trials

Clinical Trial Summary for Sevirumab

Top disease conditions for Sevirumab
Top clinical trial sponsors for Sevirumab

See all Sevirumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.